ORTHOFIX MEDICAL INC. OFIX
9.44
0.28
3.06%
as of 25 Sep
- Market cap
- $373.1M
- P/E
- 0.0×
Follow OFIX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.71 | 0.73 | 0.56 | 0.45 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
46.94 | 21.68 | (26.35) | (60.07) | |
P/B ratio |
1.32 | 1.33 | 1.07 | 0.87 | |
Price to Tangible BV |
3.39 | 3.29 | 2.71 | 2.22 | |
EV/Sales |
0.85 | 0.85 | 0.71 | 0.61 | |
EV/EBITDA |
135.49 | 380.93 | 38.57 | 26.35 | |
EV/Operating CF |
23.72 | 20.87 | 17.10 | 31.37 | |
EV/FCF |
(133.74) | (193.86) | (86.67) | (16.93) | |
Quick Ratio |
1.23 | 1.30 | 1.61 | 1.53 | |
Current Ratio |
2.47 | 2.45 | 2.87 | 2.84 | |
Net Debt/EBITDA |
(43.01) | 5.75 | 986.10 | 20.89 | |
Debt/Assets |
20.95% | 20.51% | 26.42% | 26.86% | |
Debt/Equity |
0.39 | 0.39 | 0.54 | 0.55 | |
Asset Turnover |
0.96 | 0.94 | 0.97 | 0.97 | |
Operating CF/Net income |
(0.54) | (12.46) | 0.84 | 0.39 | |
Capex/Depreciation |
(0.68) | (0.72) | (0.73) | (0.88) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.18% | 6.99% | 7.79% | 7.56% | |
Selling, General and Administrative Expense of Revenue |
72.02% | 62.19% | 68.58% | 65.44% | |
Intangible Assets out of Total Assets |
0.33 | 0.31 | 0.30 | 0.30 | |
Share Based Compensation of Revenue |
3.49% | 3.28% | 3.32% | 3.67% | |
Graham Net Nets |
0.01 | 0.03 | 0.02 | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(20.70%) | (15.44%) | (13.16%) | (16.85%) | |
Free Cash Flow Yield |
(0.90%) | (0.60%) | (1.45%) | (8.06%) | |
Revenue per Share |
5.17 | 5.55 | 4.86 | 5.16 | |
Operating CF per Share |
0.31 | 0.70 | (0.44) | (0.15) | |
Capex per Share |
(0.25) | (0.27) | (0.26) | (0.31) | |
Free Cash Flow per Share |
0.06 | 0.42 | (0.70) | (0.46) | |
Cash per Share |
1.66 | 2.15 | 2.99 | 2.55 | |
Shareholders Equity per Share |
11.13 | 11.36 | 10.76 | 10.49 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.13 | 11.36 | 10.76 | 10.49 | |
Free Cash Flow |
2.50 | 16.82 | (28.27) | (18.87) | |
Working Capital |
234.32 | 246.37 | 300.49 | 289.12 | |
Capital Expenditures |
(9.90) | (10.88) | (10.66) | (12.65) | |
Net Current Asset Value |
4.05 | 16.24 | 10.11 | 2.29 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.06 | |
Net Profit Margin |
(11.09%) | (1.01%) | (10.63%) | (7.49%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
127.83 | 135.23 | 134.82 | 132.69 | |
Average Payables |
48.76 | 53.60 | 49.93 | 54.31 | |
Average Inventory |
189.93 | 180.89 | 176.15 | 178.73 | |
Average Assets |
850.24 | 871.97 | 854.87 | 855.09 | |
Average Common Equity |
484.21 | 476.58 | 446.74 | 443.76 |
Columns are period end dates